Drugs on the Horizon for Colorectal Cancer Dana B. CardinJordan D. Berlin ReviewPaper 04 June 2011 Pages: 191 - 199
Updates on Rectal Cancer Marco ZoccaliMukta KraneAlessandro Fichera ReviewPaper 24 May 2011 Pages: 200 - 210
Why Cetuximab is Not Active in the Adjuvant Setting Joseph C. MurrayChristina S. WuLouis M. Weiner ReviewPaper 25 June 2011 Pages: 211 - 217
Should We Perform a New Adjuvant Trial with Bevacizumab? Arvind DasariWells A. Messersmith ReviewPaper 14 June 2011 Pages: 218 - 226
Biological Markers in Patients with Early-Stage Colon Cancer: Consensus and Controversies Kathryn M. FieldJohn R. Zalcberg ReviewPaper 28 June 2011 Pages: 227 - 240
Reduced Chemotherapy Duration: A Good Idea? Joleen HubbardAxel Grothey ReviewPaper 10 June 2011 Pages: 241 - 245
Is There a Future for Bevacizumab in the Adjuvant Setting After the C-08 and AVANT Trials? Rachel P. RiechelmannPaulo M. HoffAimery de Gramont ReviewPaper 28 May 2011 Pages: 246 - 251